IEM Donates Medical Supplies to Texas Children’s Hospital

IEM and IEM Health are honored to donate emergency medical kits, automated external defibrillators, and other medical supplies to Texas Children’s Hospital, the largest pediatric hospital system in the nation.

“Equipping medical centers with the proper resources could provide a lifeline for the communities they serve,” said IEM Health Chief Medical Director Dr. Rashid Chotani. “These items will be invaluable tools to be used in emergency situations, educate first responders, and ultimately to save lives. We hope the pediatric doctors, staff, patients, and their families benefit greatly from IEM’s donation.”

In November 2022, Texas Children’s Hospital and Baylor College of Medicine announced plans to lead the Gulf 7 – Pediatric Disaster Network (G7). This regional pediatric disaster network provides specialized care during widespread crises in Alabama, Florida, Georgia, Louisiana, Mississippi, Puerto Rico, and Texas. G7 works to improve regional capacity to provide pediatric care in large-scale crises and serves as a hub for disaster-focused education, training, and resource deployment.

Chotani and Deputy Director of IEM Health Dr. Lori Van Wagenen presented the items to Dr. Brent Kaziny, Medical Director of Emergency Management and Attending Physician, Emergency Center at Texas Children’s Hospital.

“As health care professionals and providers, we have a responsibility to our hospital, our city, and our community to prepare for disasters and to respond to them as quickly and effectively as possible,” said Dr. Kaziny. “We are so grateful for IEM’s generous donation, which will enhance our preparedness by providing us with the tools we need to train our staff and to educate first responders.”

Kaziny also serves as Co-Director, Disaster Preparedness Domain, EMS for Children Innovation and Improvement Center and Department of Pediatrics, Section of Emergency Medicine, Baylor College of Medicine.

“Coordinating attainable medical care for children from an expansive network of experts in times of crisis aligns with IEM’s mission,” Chotani added. “IEM Health is proud to have had the opportunity to deliver highly specialized and efficient, quality supplies that will help people of all ages, including the youngest survivors of disasters and emergencies.”

SourceIEM

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”